4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000109
Chairperson & CEO sold 9,500 shares at an average $522.37 ($4,962,488)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-29 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-07-29 | Sale : show line 2 in the form 10b5-1 | −798 | $518.25 | $413,565 | 333,145 | I |
| 2026-07-29 | Sale : show line 3 in the form 10b5-1 | −1,112 | $519.29 | $577,453 | 332,033 | I |
| 2026-07-29 | Sale : show line 4 in the form 10b5-1 | −900 | $520.40 | $468,364 | 331,133 | I |
| 2026-07-29 | Sale : show line 5 in the form 10b5-1 | −1,270 | $521.32 | $662,078 | 329,863 | I |
| 2026-07-29 | Sale : show line 6 in the form 10b5-1 | −880 | $522.51 | $459,813 | 328,983 | I |
| 2026-07-29 | Sale : show line 7 in the form 10b5-1 | −1,318 | $523.63 | $690,138 | 327,665 | I |
| 2026-07-29 | Sale : show line 8 in the form 10b5-1 | −1,982 | $524.47 | $1,039,503 | 325,683 | I |
| 2026-07-29 | Sale : show line 9 in the form 10b5-1 | −1,240 | $525.46 | $651,575 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $522.37 · $4,962,488 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-29 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option | −9,500 | 246,410 | I |
Loading xslF345X06/primarydocument.xml…